Rockwell Medical, Inc. (RMTI): Total Assets
$57.15M
As of 2025-12-31
$56.53M
As of 2026-06-30
+7.0%
3-year compound annual growth
-6.0%
5-year compound annual growth
-4.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $57.15M | -3.5% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $59.21M | +13.5% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $52.17M | +11.9% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $46.63M | -4.0% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $48.57M | -37.5% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $77.75M | +75.4% | 2022-04-08, Balance as of period end |
| 2019-12-31 | $44.32M | -15.7% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $52.56M | -10.6% | 2020-03-17, Balance as of period end |
| 2017-12-31 | $58.78M | -29.3% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $83.15M | -5.3% | 2018-03-15, Balance as of period end |
| 2015-12-31 | $87.82M | -10.4% | 2017-03-15, Balance as of period end |
| 2014-12-31 | $98.00M | +169.5% | 2016-02-29, Balance as of period end |
| 2013-12-31 | $36.36M | +113.6% | 2015-03-03, Balance as of period end |
| 2012-12-31 | $17.03M | -46.7% | 2014-03-07, Balance as of period end |
| 2011-12-31 | $31.94M | -13.6% | 2013-03-18, Balance as of period end |
| 2010-12-31 | $36.97M | n/a | 2012-03-05, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $57.15M | -3.5% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $899.42M | +21.1% |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | $738.36M | -2.9% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $68.92M | -37.7% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $257.59M | +116.2% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $717.60M | -25.0% |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | $280.73M | -25.5% |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | $1.36B | -0.3% |
| Fortress Biotech, Inc. (FBIO) | 2025-12-31 | $185.55M | +28.7% |
Compare RMTI, VRDN, KURA, SPRO side by side · Screen every company in Pharmaceutical Preparations ↗